Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
This study is recruiting. It focuses on ADHD and currently lists participation information in the United States.
In Memphis
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on ADHD and currently lists participation information in the United States.
In MemphisThis study is recruiting. It focuses on bipolarity and currently lists participation information in the United States.
In MinneapolisThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In Chapel HillThis study is recruiting. It focuses on depression and currently lists participation information in India.
Multiple locations, including ChandīgarhThis study is recruiting. It focuses on anxiety and currently lists participation information in the United States.
Multiple locations, including LivingstonThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In West Los AngelesThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In Ann ArborThis study is recruiting. It focuses on PTSD and currently lists participation information in the United States.
In RichmondThis study is recruiting. It focuses on suicide prevention and currently lists participation information in the United States.
Multiple locations, including BirminghamThis study is recruiting. It focuses on depression and currently lists participation information in Australia.
In AustraliaThis study is recruiting. It focuses on depression and currently lists participation information in the Netherlands.
In NetherlandsThis study is recruiting in the United Kingdom. It is testing MILESTONE (Emotional Cognitive Bias Modification for depression.
In United KingdomHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.